DOKTERS OLIVIER en DEVOS
ActiveSummary
DOKTERS OLIVIER en DEVOS has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.6m and a net result of €318,136. Equity has been growing by about 21% per year since 2019. Its solvency ranks better than 95% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 01-09-2010 Normal situation
- Activity
- Scientific research and development NACE 72200and 1 other
- Establishment unit
- 2.192.994.311 8470 Gistel, since 04-11-2010
- Financial year end
- 30 September
- Peppol
- Reachable since 22-05-2024
Board and ownership
- OLIVIER, Frederick Johannes AlbertusDirector · since 01-09-2010
- DEVOS, Els Judith MagdalenaDirector · since 01-01-2014
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €442,422
- ▼ 29.9%
- Turnover
- ≈ €1.0m
- estimated
- Profit
- €318,136
- ▼ 27.9%
- Equity
- €1.6m
- ▲ 24.0%
- Total assets
- €1.6m
- ▲ 12.4%
Score breakdownlowers riskLiquidity: current ratio 526.95, cash €492,813Equity €1.6m (99.8% of total assets)Figures for financial year 2025 (filed on 17-04-2026)Size: total assets €1.6mShow the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 76% on liquidity, 74% on profitability and 76% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: Higher solvency than 95% of companies in research and developmentsector median 45.5% · 271 companies 99.8% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 7 profitable years in a rowprofit 2025: €318,136 7 years View
- Caution: Result fell in 2025from €441,398 to €318,136 ▼ 27.9% View
Recent changes
- · Gazette deed Resignations: OLIVIER, Frederick Johannes Albertus (manager) and DEVOS, Els Judith Magdalena (manager)Reappointments: OLIVIER, Frederick Johannes Albertus (director) and DEVOS, Els Judith Magdalena (director)
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as DOKTERS OLIVIER en DEVOS: scientific research and development (NACE 72200). They are comparable in size and age: total assets between €985,000 and €1.9m, founded between 2004 and 2014.
| Company | Total assets | Gross margin |
|---|---|---|
| DOKTERS OLIVIER en DEVOS Gistel | €1.6m | €0.4m |
| DR. MERCKAERT KATHLEEN, HUISARTS Geraardsbergen | €1.2m | €0.4m |
| EUROPEAN FUTURE INNOVATION SYSTEM CENTRE Ottignies-Louvain-la-Neuve | €1.4m | €0.5m |
| Dr. Hellebuyck Hans Middelkerke | €1.9m | €0.6m |
| Artsenpraktijk Dr. Blondeel - Dr. Pycke Oudenaarde | €1.7m | €0.3m |
| RHUMATH Ath | €1.4m | €0.2m |
| DOKTER JOKE PRAET Meise | €1.0m | €0.2m |
Key facts about DOKTERS OLIVIER en DEVOS
- What is the company number of DOKTERS OLIVIER en DEVOS?
- The company number of DOKTERS OLIVIER en DEVOS is 0829.094.830. The VAT number is the same number with BE in front: BE 0829.094.830.
- Where is DOKTERS OLIVIER en DEVOS based?
- The registered office is at Sylveer Maesstraat 10, 8470 Gistel.Company details
- What does DOKTERS OLIVIER en DEVOS do?
- According to the KBO register, the main activity is scientific research and development (NACE 72200).
- What is the legal form of DOKTERS OLIVIER en DEVOS?
- The legal form of DOKTERS OLIVIER en DEVOS is Private limited company (BV).
- When was DOKTERS OLIVIER en DEVOS founded?
- DOKTERS OLIVIER en DEVOS was founded on 01-09-2010.
- Is DOKTERS OLIVIER en DEVOS still active?
- Yes, DOKTERS OLIVIER en DEVOS is an active enterprise in the KBO register.
- What is the turnover of DOKTERS OLIVIER en DEVOS?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €442,422 and 2,283 comparable companies of the same size. It probably lies between €630,000 and €1.8m. It is a rough estimate.Financials
- Is DOKTERS OLIVIER en DEVOS profitable?
- In financial year 2025, DOKTERS OLIVIER en DEVOS made a profit of €318,136.
- Where can I find the annual accounts of DOKTERS OLIVIER en DEVOS?
- DOKTERS OLIVIER en DEVOS filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DOKTERS OLIVIER en DEVOS due?
- DOKTERS OLIVIER en DEVOS must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.